Construction Competitiveness Evaluation System of Regional BioPharma Industry and Case Study: Taking Shijiazhuang as an Example

Bing Zhao, Dong Sheng Zhang and Yong Zheng Zhao
Additional contact information
Bing Zhao: Hebei University of Technology and Shijiazhuang University, China
Dong Sheng Zhang: Hebei University of Technology, China
Yong Zheng Zhao: CSPC Pharmaceutical Group Limited, China

International Journal of Advanced Pervasive and Ubiquitous Computing (IJAPUC), 2011, vol. 3, issue 2, 13-20

Abstract: Biological pharmaceutical industry not only has the continuous pulling action to region economy, also makes a positive contribution on the human productivity and quality of life. Biological pharmaceutical industry will become the leading industry of the century in quite a long time in the future. Taking Shijiazhuang as an example, according to the regional biopharmaceutical industry planning needs, building the industry competitiveness evaluation system, this paper analyzes the comparative advantage of Shijiazhuang in developing bio-pharmaceutical industry from 4 level evaluation index, including: the industry environment and policy, R & D capability, competitiveness of economic scale and industry support system. Provide a reference for local governments and business.

Date: 2011
References: Add references at CitEc
Citations:

Downloads: (external link)
http://services.igi-global.com/resolvedoi/resolve. ... 018/japuc.2011040102 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:igg:japuc0:v:3:y:2011:i:2:p:13-20

Access Statistics for this article

International Journal of Advanced Pervasive and Ubiquitous Computing (IJAPUC) is currently edited by Tao Gao

More articles in International Journal of Advanced Pervasive and Ubiquitous Computing (IJAPUC) from IGI Global
Bibliographic data for series maintained by Journal Editor ().